S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
US Dollar Replaced By "Biden Bucks"? (Ad)
NASDAQ:MEDP

Medpace - MEDP Earnings Date, Estimates & Call Transcripts

$169.16
+0.47 (+0.28%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$166.99
$170.45
50-Day Range
$132.27
$169.53
52-Week Range
$126.94
$231.00
Volume
249,855 shs
Average Volume
343,469 shs
Market Capitalization
$5.24 billion
P/E Ratio
29.37
Dividend Yield
N/A
Price Target
$175.00

Earnings Summary

Upcoming
Earnings Date
Oct. 24Estimated
Actual EPS
(Jul. 25)
$1.46 Beat By $0.13
Consensus EPS
(Jul. 25)
$1.33
Last Year's Q3 EPS
(7/25/2021)
$1.06
Skip Charts & View Estimated and Actual Earnings Data

MEDP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MEDP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medpace Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20223$1.27$1.28$1.28 
Q2 20223$1.29$1.42$1.34 
Q3 20223$1.41$1.52$1.46 
Q4 20223$1.50$1.55$1.52 
FY 202212$5.47$5.77 $5.59

MEDP Earnings Date and Information

Medpace last posted its quarterly earnings data on July 25th, 2022. The reported $1.46 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.13. The company earned $351.21 million during the quarter, compared to analysts' expectations of $344.01 million. Its revenue for the quarter was up 26.2% on a year-over-year basis. Medpace has generated $5.76 earnings per share over the last year ($5.76 diluted earnings per share) and currently has a price-to-earnings ratio of 29.4. Earnings for Medpace are expected to grow by 5.68% in the coming year, from $6.16 to $6.51 per share. Medpace has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 24th, 2022 based off prior year's report dates.

Medpace Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/24/2022
(Estimated)
        
7/25/2022Q2$1.33$1.46+$0.13$344.01 million$351.21 million    
4/25/2022Q1 2022$1.26$1.69+$0.43$1.69$327.09 million$330.90 million    
2/13/2022Q4 2021$1.25$1.32+$0.07$1.32$309.03 million$308.55 million    
10/24/20219/30/2021$1.07$1.29+$0.22$1.29$291.55 million$295.57 million    
7/25/20216/30/2021$0.99$1.06+$0.07$1.06$271.20 million$278.29 million    
4/25/20213/31/2021$1.01$1.14+$0.13$1.20$266.48 million$260.00 million  
2/14/202112/31/2020$1.24$1.35+$0.11$1.43$246.41 million$259.68 million  
10/31/20209/30/2020$1.07$1.09+$0.02$1.17$223.56 million$230.37 million  
7/27/20206/30/2020$0.40$0.68+$0.28$0.72$181.17 million$205.00 million  
4/28/20203/31/2020$0.77$0.76($0.01)$0.76$226.23 million$230.88 million  
2/24/2020Q4 2019$0.75$0.85+$0.10$0.92$221.73 million$229.89 million  
10/29/2019Q3 2019$0.71$0.71$0.79$217.14 million$216.20 million  
7/29/2019Q2$0.63$0.81+$0.18$0.89$200.99 million$214.10 million
4/29/20193/31/2019$0.60$0.64+$0.04$0.77$190.16 million$200.70 million
2/25/2019Q4 2018$0.69$0.76+$0.07$0.91$184.66 million$192.12 million  
11/1/20189/30/2018$0.63$0.67+$0.04$0.82$175.07 million$179.00 million  
7/31/2018Q2 2018$0.42$0.61+$0.19$0.77$104.97 million$117.80 million
4/30/2018Q1 2018$0.43$0.60+$0.17$0.75$113.12 million$108.40 million  
2/26/2018Q4 2017$0.38$0.39+$0.01$0.48$97.25 million$99.45 million  
10/30/2017Q3 2017$0.36$0.40+$0.04$0.55$96.84 million$98.68 million
7/31/2017Q2 2017$0.30$0.38+$0.08$0.53$92.71 million$94.60 million
5/1/2017Q1 2017$0.37$0.34($0.03)$0.48$93.61 million$93.80 million  
2/27/2017Q416$0.34$0.35+$0.01$0.70$94.40 million$95.38 million  
11/3/2016Q316$0.34$0.40+$0.06$0.57$91.42 million$94.80 million  












Medpace Earnings - Frequently Asked Questions

When is Medpace's earnings date?

Medpace has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 24th, 2022 based off last year's report dates. Learn more on MEDP's earnings history.

Did Medpace beat their earnings estimates last quarter?

In the previous quarter, Medpace (NASDAQ:MEDP) reported $1.46 earnings per share (EPS) to beat the analysts' consensus estimate of $1.33 by $0.13. Learn more on analysts' earnings estimate vs. MEDP's actual earnings.

How can I listen to Medpace's earnings conference call?

The conference call for Medpace's latest earnings report can be listened to online. Listen to Conference Call

How can I read Medpace's conference call transcript?

The conference call transcript for Medpace's latest earnings report can be read online. Read Transcript

How much revenue does Medpace generate each year?

Medpace (NASDAQ:MEDP) has a recorded annual revenue of $1.14 billion.

How much profit does Medpace generate each year?

Medpace (NASDAQ:MEDP) has a recorded net income of $181.85 million. MEDP has generated $5.76 earnings per share over the last four quarters.

What is Medpace's price-to-earnings ratio?

Medpace (NASDAQ:MEDP) has a trailing price-to-earnings ratio of 29.37 and a forward price-to-earnings ratio of 27.46.

What is Medpace's EPS forecast for next year?

Medpace's earnings are expected to grow from $6.16 per share to $6.51 per share in the next year, which is a 5.68% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:MEDP) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.